«Oligodendroglia

Below is an extended Oligodendroglia patents listing. Click here to return to the Oligodendroglia main in depth entry.

Patents :
US Patent No.	Title
6828145	Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
7074911	Endogenous granzyme B in non-immune cells
7098027	Method for remyelinating a demyelinized lesion due to injury in the brain or spinal cord
7101709	Methods of screening biological agents
7105342	Multipotent neural stem cell cDNA libraries
7105485	HO-1 suppressor as a diagnostic and prognostic test for dementing diseases
7115418	Methods of proliferating undifferentiated neural cells
7129034	Differentiation of whole bone marrow
7141549	Proteins and nucleic acids encoding same
7153883	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
7157418	Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
7067254	Diagnosis and treatment of inflammation and hyperactive immune conditions
7041507	Transdiffentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
7022321	Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system
6846641	In vitro ischemia model
6869600	Combined treatment of multiple sclerosis
6884784	Diagnosis and management of infection caused by chlamydia
6921775	Methods for modulating brain damage
6929922	Methods for the detection of demyelinating diseases
6949380	Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells
6953687	Vectors for delivering viral and oncogenic inhibitors
6964849	Proteins and nucleic acids encoding same
6991901	Proteins and nucleic acids encoding same
7011828	Implanting neural progenitor cells derived for human embryonic stem cells
7166277	Remyelination of neurons using multipotent neural stem cell progeny
7166702	Cytotoxic conjugates comprising a chemokine receptor targeting agent
7297099	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7320872	Ependymal neural stem cells and method for their isolation
7338976	Heterocyclic esters or amides for vision and memory disorders
7361505	Multipotent neural stem cell compositions
7361506	Differentiation of specialized dermal and epidermal cells into neuronal cells
7361517	Real time method of detecting acute inflammatory conditions
7368115	Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (PACAP)
7390631	Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
7393830	Prolactin induced increase in neural stem cell numbers
7402303	Chemokine mutants in the treatment of multiple sclerosis
7285573	Use of creatine or creatine analogs for the treatment of diseases of the nervous system
7285415	Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
7279332	Method of isolating ependymal neural stem cells
7189703	Treatment and diagnosis of alzheimer's disease
7192736	Nucleic acid molecules encoding cytotoxic conjugates that contain a chemokine receptor targeting agent
7196188	Methods and compositions for screening of human borna disease virus
7201896	IL6RIL6 chimera for the treatment of neurodegenerative diseases
7217687	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7226780	Lentivirus vector system
7255887	Use of Bowman Birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
7256252	Methods for detecting cell apoptosis
7265150	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
7276593	Proteins and nucleic acids encoding same
7410995	N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.